Abbott Laboratories Limited informed Pakistan Stock Exchange that the Securities and Exchange Commission of Pakistan has approved the Company's request for an extension until 30 May, 2020 for preparing the financial statements for the first quarter that ended on March 31, 2020. The date, time and venue of the Board meeting to consider the financial statements for the first quarter that ended on March 31, 2020 and the closed period will be notified in due course.

The announcement is available at:

https://dps.psx.com.pk/download/document/145533.pdf

Abbott Laboratories Limited is a public limited company. It was incorporated in Pakistan on July 2, 1948. Abbott started operations in Pakistan as a marketing affiliate in 1948. The company is engaged in the manufacturing, importing and marketing of research based pharmaceutical, nutritional, diagnostic, diabetic care, molecular devices, and hospital and consumer products. The company also provides toll manufacturing services. The stocks of the company are quoted on the Karachi, Lahore and Islamabad stock exchanges of Pakistan. The registered office of the company is located in Karachi.

Abbott Pakistan is part of the global healthcare corporation of Abbott Laboratories, Chicago, USA. It has over 70,000 employees worldwide and a global presence in more than 130 countries. It has a work force of over 1500 employees. Besides this the company has two manufacturing facilities located at Landhi and Korangi in Karachi.

The symbol "ABOT" is being used by the stock exchanges for the shares of Abbott Laboratories Limited.

© Pakistan Press International, source Asianet-Pakistan